Global Biodefense Market

Biodefense Market Insights

The global biodefense market is estimated to witness a high CAGR during the forecast period (2019-2026). Growing awareness regarding bioterrorism attacks in developed countries is one of the major factors driving the market growth during the forecast period. Favorable government regulations along with growing healthcare expenditure in developing nations is also propelling the market growth for biodefense. However, low R&D funding for manufacturing vaccines against bioterrorism attacks by government in developing and underdeveloped countries are likely to hamper the market growth during the forecast period.

Biodefense Market: By Product

On the basis of product, the global biodefense market is segmented into vaccines and biothreat detection devices. The vaccines segment is expected to hold the largest market share during the forecast period. The vaccine segment is further segmented into anthrax, smallpox, and botulism among others. Increasing expenditures in R&D by pharmaceutical and biopharmaceutical companies across the globe is driving the market for vaccines. Vaccines have flexibility to address various bioterrorism agents and possess ability to generate a long-lasting immune response after a single oral dose.

Bio-threat detection segment is expected to grow at a significant CAGR during the forecast period. The bio-detection segment is further segmented into samplers, detectors/triggering devices, identifiers, assays and reagents among others. Bio-threat detection device is used for analyzing DNA from a sample to efficiently detect the presence of infectious, bacterial or fungal agent within a short time span. Growing adoption of rapid bio-threat detection systems in clinical trials and research centers are driving the market growth.

Biodefense Market: By Region

North America region is expected to dominate the market during the forecast period. The U.S. and Canada governments are implementing several initiatives for strengthening security against bioterrorism attacks. Government has also planned several biodefense programs such as pandemic influenza and infectious disease program among others in the U.S. Asia Pacific region is expected to grow at the highest CAGR during the forecast period. Rising government initiatives and funding to prevent bioterrorism in developing nations such as India, China and Japan will positively influence the industry growth during the forecast period.

Biodefense Market: End Use Landscape

The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase. The key end-users of the markets are Mayo clinic, Singapore Hospital and Apollo among others.

Biodefense Market: Vendor Landscape

The report contains a chapter dedicated to vendors operating in the Biodefense market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.

Biodefense Market Share & Competitor Analysis

Some of the key players operating in the biodefense market are Altimmune, Emergent BioSolutions, SIGA Technologies, Elusys Therapeutics, Ichor Medical Systems, DynPort Vaccine Company, Cleveland BioLabs, Bavarian Nordic, Achaogen, Alnylam Pharmaceuticals, PathSensors and BBI Detection among others

In January 2017, Altimmune merged with PharmAthenemer to develop next generation anthrax vaccine utilized in biodefense.

Please note: This is not an exhaustive list of companies profiled in the report.

Check the Press Release on Global Biodefense Market Report